Vivalyx was founded by Benedict Doorschodt.

Who are Vivalyx's investors?

Vivalyx's investors include GOOSE Capital, NextGen Ventures, Seed Fonds Aachen, TechVision Fonds, TechVision Fund, Bessemer Venture Partners, Brightlands Venture Partners, Springboard Health Angels.

Where is Vivalyx headquartered?

Vivalyx is headquartered in Aachen, DE.

Vivalyx

Aachen, DE · 10 known investors

Find your way into Vivalyx

Paths you didn't know you had: your email and LinkedIn already hold routes to the Vivalyx team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Vivalyx develops organ revitalization technology aimed at improving organ vitality for transplantation. The company works in the medical biotechnology field.

Biotech Healthtech Medical Devices

Founders & leadership

Benedict Doorschodt FounderBenedict Doorschodt is Chief Technology Officer and Founder of Vivalyx, a medical biotechnology company developing organ revitalization technology. He has over 20 years of experience in medical device development and life cycle management, and leads the company's research and development, preclinical and clinical strategy work.

Investors · 10

GOOSE Capitallisted by GOOSE CapitalHouston

How we know: GOOSE Capital's portfolio page · startbase.com · Not right? Tell us

NextGen Ventureslisted by NextGen VenturesEde

How we know: NextGen Ventures's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

Seed Fonds Aachenlisted by Seed Fonds AachenAachen · $545K – $2.2M

How we know: Seed Fonds Aachen's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

TechVision Fondslisted by TechVision FondsAachen · $540K – $2.2M

How we know: TechVision Fonds's portfolio page · funding news · startbase.com · Not right? Tell us

TechVision Fundlisted by TechVision FundAachen · $500K – $2M

How we know: TechVision Fund's portfolio page · Not right? Tell us

Bessemer Venture PartnersreportedSan Francisco · $50K – $100M

How we know: funding news · Not right? Tell us

Brightlands Venture PartnersreportedGeleen · $540K – $2.2M

How we know: funding news · startupsmagazine.co.uk · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

Springboard Health AngelsreportedBerlin

How we know: startbase.com · Not right? Tell us

Also in the syndicate · 2

Arve CapitalBrightlands Venture Partners (BVP)lead

Funding

SEC filings, press & company announcements

Undisclosed amountSeedMay 2024
Source ↗
Undisclosed amountSeed roundApr 2024 · 3 sources
Brightlands Venture Partners (BVP) (lead), TechVision Fonds (TVF) (lead), Arve Capital, Brightlands Venture Partners, Goose Capital, Springboard Health Angels
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Vivalyx Raises €5.4M in Seed Fundingfinsmes.com · May 2024

Vivalyx 5/1/2024 Capital Raise - Gaebler.com Venture Capital Databasegaebler.com

Frequently asked questions

What does Vivalyx do?: Vivalyx develops organ revitalization technology aimed at improving organ vitality for transplantation. The company works in the medical biotechnology field.
Who founded Vivalyx?: Vivalyx was founded by Benedict Doorschodt.
Who are Vivalyx's investors?: Vivalyx's investors include GOOSE Capital, NextGen Ventures, Seed Fonds Aachen, TechVision Fonds, TechVision Fund, Bessemer Venture Partners, Brightlands Venture Partners, Springboard Health Angels.
Where is Vivalyx headquartered?: Vivalyx is headquartered in Aachen, DE.